2nd Neuroimmunology Drug Development Summit

Memo

The Industry's Definitive Conference Specifically Designed to Overcome the Translational Challenges of Neuroimmunological Drug Development Focused on neurodegenerative diseases such as Parkinson's, Alzheimer's and ALS, and with over 23 speakers from leading drug developers including Biogen, Alector, andJanssen, the 2nd Annual Neuroimmunology Drug Development Summit will enable you to:- Discover the latest advances in recapitulating human microglia in preclinical models to reduce the translational gap- Hear about the successful investment strategies helping small biotechs to pursue novel targets- Discuss how to approach neuroimmunological targets to improve the efficacy of neurodegenerative therapeutics- Review the latest clinical data with neuroimmunological candidates to inform future research- Network with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations Join over 80 members the neuroimmunology drug development community for an unrivaled learning and networking experience with the leading organizations on the cutting-edge of this exciting and fast-moving space to create opportunities for future collaborations. URLs:Tickets: https://go.evvnt.com/566897-0?pid=5569 Brochure: https://go.evvnt.com/566897-3?pid=5569  Date and Time: On Wednesday April 15, 2020 at 9:00 am ends Friday April 17, 2020 at 5:00 pm Venue details: The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States Prices:Conference + 2 Workshops: USD 4297.00,Conference + 1 Workshop: USD 3698.00,Conference Only: USD 3099.00,Workshop Only: USD 699.00 Speakers: Andrea Crotti, Astellas, Anindya Bhattacharya, Janssen, Christian Haass, University of Munich, David Hansen, Genentech, Dimitry Ofengeim, Sanofi, Eduard Urich, Roche, Jamie Bilsland, AstronauTx, Jane Osbourn, Alchemab, Johan Luthman, Lundbeck, Jonathan Behr, Dementia Discovery Fund, Karel Otero-Gutierrez, Eisai, Karpagam Shalu Srinivasan, Alector, Malu Tansey, The University of Florida College of Medicine, Maria Carrillo, Alzheimer’s Association, Matt Blurton-Jones, University of California, Irvine, Matthew Fell, Merck Research Laboratories, Rebecca Mathew, Merck Research Laboratories, Richard Ransohoff, Third Rock Ventures, RJ Tesi, INmune Bio, Robert Paul, Alector, Sue Bruhn, Tiaki Therapeutics